Anna Casati
Overview
Explore the profile of Anna Casati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schonberger S, Kraft D, Nettersheim D, Schorle H, Casati A, Craveiro R, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32438548
Outcome in high-risk patients with refractory or relapsed germ cell tumours (GCT) remains poor. Novel strategies enhancing therapeutic efficacy whilst limiting therapeutic burden are warranted, yet immunotherapy approaches geared towards...
2.
Foresti S, Perego M, Carugati M, Casati A, Malafronte C, Manzoni M, et al.
Int J Infect Dis
. 2019 Jun;
85:88-91.
PMID: 31150844
Case Presentation: 77-year-old former smoker admitted because of fatigue and abdominal distention. Past medical history positive for two previous hospitalizations for pericardial and pleural effusions (no diagnosis achieved). At admission...
3.
Ehrhardt M, Craveiro R, Velz J, Olschewski M, Casati A, Schonberger S, et al.
J Cell Mol Med
. 2018 Jan;
22(4):2153-2161.
PMID: 29377550
Aberrant receptor kinase signalling and tumour neovascularization are hallmarks of medulloblastoma development and are both considered valuable therapeutic targets. In addition to VEGFR1/2, expression of PDGFR α/β in particular has...
4.
Schonberger S, van Beekum C, Gotz B, Nettersheim D, Schorle H, Schneider D, et al.
J Cell Mol Med
. 2017 Sep;
22(1):568-575.
PMID: 28941150
Prognosis in patients suffering from high-risk, refractory and relapsed germ cell tumours (GCT) often comprising of CD30-positive embryonal carcinoma (EC) components remains poor. Thus, novel treatment strategies are warranted. The...
5.
Cuspidi C, Sala C, Casati A, Bombelli M, Grassi G, Mancia G
Hypertens Res
. 2016 Nov;
40(4):329-335.
PMID: 27853165
Because subclinical alterations in cardiovascular structure reflect cumulative damage induced by risk factors and represent an intermediate stage between risk factor exposure and cardiovascular events, this damage is regarded as...
6.
Grassi G, Quarti-Trevano F, Casati A, DellOro R
Curr Atheroscler Rep
. 2016 Oct;
18(12):70.
PMID: 27771852
Purpose Of Review: Detection of elevated blood pressure values in elderly patients represents a common clinical condition associated with an increased cardiovascular risk. This has been shown to be the...
7.
Seravalle G, Brambilla G, Pizzalla D, Casati A, Riva M, Cuspidi C, et al.
J Am Soc Hypertens
. 2016 Feb;
10(3):244-51.
PMID: 26831124
Scanty information is available on the effects of combination drug treatment based on an ACE inhibitor and a calcium channel blocker on the neurometabolic alterations characterizing obesity-related hypertension (OHT). After...
8.
Casati A, Varghaei-Nahvi A, Feldman S, Assenmacher M, Rosenberg S, Dudley M, et al.
Cancer Immunol Immunother
. 2013 Aug;
62(10):1563-73.
PMID: 23903715
The adoptive transfer of lymphocytes genetically engineered to express tumor-specific antigen receptors is a potent strategy to treat cancer patients. T lymphocyte subsets, such as naïve or central memory T...
9.
Marrella V, Poliani P, Fontana E, Casati A, Maina V, Cassani B, et al.
Blood
. 2012 Jun;
120(5):1005-14.
PMID: 22723555
Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of...
10.
Traggiai E, Casati A, Frascoli M, Porcellini S, Ponzoni M, Sanvito F, et al.
PLoS One
. 2010 Jun;
5(6):e11262.
PMID: 20582316
Inflammation promotes granulopoiesis over B lymphopoiesis in the bone marrow (BM). We studied B cell homeostasis in two murine models of T cell mediated chronic inflammation, namely calreticulin-deficient fetal liver...